Mordor Intelligence has published a new report on the Oligonucleotide Synthesis Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The global oligonucleotide synthesis market is projected to grow from USD 3.84 billion in 2025 to USD 6.87 billion by 2030, registering a compound annual growth rate (CAGR) of 12.34% during the forecast period.
Oligonucleotides, short sequences of nucleotides, are essential tools in molecular biology, diagnostics, and therapeutics. Their applications span from serving as primers in polymerase chain reactions (PCR) to acting as therapeutic agents in treating genetic disorders. The increasing demand for personalized medicine, advancements in synthetic biology, and the need for rapid diagnostic solutions have significantly contributed to the market’s growth.
Oligonucleotide Synthesis Market Key Trends
-
Therapeutic Applications in Genetic Disorders
The use of oligonucleotides in treating genetic disorders has gained momentum. Antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) are being developed to target specific genetic mutations. The approval of therapies like nusinersen for spinal muscular atrophy underscores the potential of oligonucleotide-based treatments. As research continues, more such therapies are expected to enter the market, driving demand for synthesized oligonucleotides.
-
Expansion in Molecular Diagnostics
Oligonucleotides play a crucial role in molecular diagnostics, especially in techniques like PCR and next-generation sequencing (NGS). The COVID-19 pandemic highlighted the importance of rapid and accurate diagnostic tools, leading to increased utilization of oligonucleotide-based assays. This trend is expected to persist, with ongoing research into infectious diseases and cancer diagnostics.
-
Growth in Synthetic Biology and Research Funding
Synthetic biology relies heavily on custom-designed oligonucleotides for gene synthesis and editing. Governments and private institutions are investing in research initiatives, such as the National Institutes of Health’s funding for genome projects, to advance our understanding of genetics and develop novel therapies. These investments bolster the demand for oligonucleotide synthesis services.
-
Advancements in Automation and High-Throughput Synthesis
Technological advancements have led to the development of automated platforms capable of high-throughput oligonucleotide synthesis. These systems enhance efficiency, reduce errors, and lower costs, making oligonucleotide synthesis more accessible to researchers and clinicians. The adoption of such technologies is expected to accelerate market growth.
-
Increasing Demand for Personalized Medicine
Personalized medicine aims to tailor treatments based on individual genetic profiles. Oligonucleotides are integral to this approach, serving as tools for gene editing, diagnostics, and targeted therapies. As the healthcare industry moves towards more individualized treatment plans, the demand for custom oligonucleotides is anticipated to rise.
Oligonucleotide Synthesis Market Segmentation
The oligonucleotide synthesis market is segmented based on product type, application, end-user, and geography:
By Product Type:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
By Application
- Research
- Therapeutics
- Diagnostics
By End-User
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
This segmentation reflects the diverse applications and user base of oligonucleotide synthesis, highlighting its significance across various sectors and regions.
Explore Our Full Library of Biotechnology Research Industry Reports –
https://www.mordorintelligence.com/market-analysis/biotechnology
Key Players
Several companies are at the forefront of the oligonucleotide synthesis market, offering a range of products and services:
- Agilent Technologies
- Thermo Fisher Scientific
- Merck KGaA
- Danaher Corporation
- Bio-Synthesis Inc.
- Eurofins Scientific
These organizations contribute to the market through continuous research, product development, and strategic collaborations, ensuring the availability of high-quality oligonucleotides for various applications.
Conclusion
The oligonucleotide synthesis market is poised for significant growth, driven by advancements in therapeutics, diagnostics, and research. The increasing emphasis on personalized medicine, coupled with technological innovations and research funding, underscores the market’s potential. As the demand for custom oligonucleotides continues to rise, stakeholders across the healthcare and research sectors are expected to invest in and benefit from this expanding market.
Industry Research Reports
Gene Synthesis Market: The Gene Synthesis Market Report is Segmented by Method (Oligonucleotide Synthesis and Gene Assembly), End User (Academic and Research Institute, Biopharmaceutical Companies, and Contract Research Organizations), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Peptide And Oligonucleotide CDMO Market : The Peptide and Oligonucleotide CDMO Market Report is Segmented by Product (Peptide CDMO and Oligonucleotide CDMO), Application (Therapeutics, Research Applications, Diagnostics, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Contract Research Organizations (CROs), and Academic and Government Organizations).
DNA Synthesis Market : The DNA Synthesis Market Report is Segmented by Product and Service (Instruments, Reagents and Consumables, and DNA Synthesis Services), Type (Oligonucleotide Synthesis and Gene Synthesis), Application (Diagnostics, Therapeutics, and Research and Development), End-User (Pharmaceutical and Biotechnology Companies, Cros and CDMOs, Academic and Research Institutes, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/